213 related articles for article (PubMed ID: 15056810)
1. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat.
Emond C; Birnbaum LS; DeVito MJ
Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810
[TBL] [Abstract][Full Text] [Related]
2. Tissue disposition of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in maternal and developing long-evans rats following subchronic exposure.
Hurst CH; DeVito MJ; Birnbaum LS
Toxicol Sci; 2000 Oct; 57(2):275-83. PubMed ID: 11006357
[TBL] [Abstract][Full Text] [Related]
3. Use of a physiologically based pharmacokinetic model for rats to study the influence of body fat mass and induction of CYP1A2 on the pharmacokinetics of TCDD.
Emond C; Birnbaum LS; DeVito MJ
Environ Health Perspect; 2006 Sep; 114(9):1394-400. PubMed ID: 16966094
[TBL] [Abstract][Full Text] [Related]
4. Disposition of polychlorinated dibenzo-p-dioxins, dibenzofurans, and non-ortho polychlorinated biphenyls in pregnant long evans rats and the transfer to offspring.
Chen CY; Hamm JT; Hass JR; Birnbaum LS
Toxicol Appl Pharmacol; 2001 Jun; 173(2):65-88. PubMed ID: 11384209
[TBL] [Abstract][Full Text] [Related]
5. A physiologically based pharmacokinetic model for developmental exposure to BDE-47 in rats.
Emond C; Raymer JH; Studabaker WB; Garner CE; Birnbaum LS
Toxicol Appl Pharmacol; 2010 Feb; 242(3):290-8. PubMed ID: 19883674
[TBL] [Abstract][Full Text] [Related]
6. In utero/lactational and adult exposures to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) show differential effects on craniofacial development and growth in rats.
Sholts SB; Korkalainen M; Simanainen U; Miettinen HM; Håkansson H; Viluksela M
Toxicology; 2015 Nov; 337():30-8. PubMed ID: 26320568
[TBL] [Abstract][Full Text] [Related]
7. 2,3,7,8-Tetrachlorodibenzo-p-dioxin in pregnant Long Evans rats: disposition to maternal and embryo/fetal tissues.
Hurst CH; Abbott BD; DeVito MJ; Birnbaum LS
Toxicol Sci; 1998 Oct; 45(2):129-36. PubMed ID: 9848119
[TBL] [Abstract][Full Text] [Related]
8. Repeated in utero and lactational 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure affects male gonads in offspring, leading to sex ratio changes in F2 progeny.
Ikeda M; Tamura M; Yamashita J; Suzuki C; Tomita T
Toxicol Appl Pharmacol; 2005 Aug; 206(3):351-5. PubMed ID: 16039946
[TBL] [Abstract][Full Text] [Related]
9. Acute administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in pregnant Long Evans rats: association of measured tissue concentrations with developmental effects.
Hurst CH; DeVito MJ; Setzer RW; Birnbaum LS
Toxicol Sci; 2000 Feb; 53(2):411-20. PubMed ID: 10696789
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
[TBL] [Abstract][Full Text] [Related]
11. Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.
Lin Z; Fisher JW; Wang R; Ross MK; Filipov NM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):140-58. PubMed ID: 23958493
[TBL] [Abstract][Full Text] [Related]
12. An assessment of dioxin exposure across gestation and lactation using a PBPK model and new data from Seveso.
Emond C; DeVito M; Warner M; Eskenazi B; Mocarelli P; Birnbaum LS
Environ Int; 2016; 92-93():23-32. PubMed ID: 27045706
[TBL] [Abstract][Full Text] [Related]
13. Toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the developing male Wistar(Han) rat. II: Chronic dosing causes developmental delay.
Bell DR; Clode S; Fan MQ; Fernandes A; Foster PM; Jiang T; Loizou G; MacNicoll A; Miller BG; Rose M; Tran L; White S
Toxicol Sci; 2007 Sep; 99(1):224-33. PubMed ID: 17545211
[TBL] [Abstract][Full Text] [Related]
14. Comparative developmental toxicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in the hamster, rat and guinea pig.
Kransler KM; McGarrigle BP; Olson JR
Toxicology; 2007 Jan; 229(3):214-25. PubMed ID: 17126467
[TBL] [Abstract][Full Text] [Related]
15. Determination of parameters responsible for pharmacokinetic behavior of TCDD in female Sprague-Dawley rats.
Wang X; Santostefano MJ; Evans MV; Richardson VM; Diliberto JJ; Birnbaum LS
Toxicol Appl Pharmacol; 1997 Nov; 147(1):151-68. PubMed ID: 9356318
[TBL] [Abstract][Full Text] [Related]
16. Toxicokinetics of 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats including placental and lactational transfer to fetuses and neonates.
Li X; Weber LW; Rozman KK
Fundam Appl Toxicol; 1995 Aug; 27(1):70-6. PubMed ID: 7589930
[TBL] [Abstract][Full Text] [Related]
17. Simulation of dioxin accumulation in human tissues and analysis of reproductive risk.
Maruyama W; Yoshida K; Tanaka T; Nakanishi J
Chemosphere; 2003 Oct; 53(4):301-13. PubMed ID: 12946389
[TBL] [Abstract][Full Text] [Related]
18. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat.
Clewell RA; Merrill EA; Yu KO; Mahle DA; Sterner TR; Mattie DR; Robinson PJ; Fisher JW; Gearhart JM
Toxicol Sci; 2003 Jun; 73(2):235-55. PubMed ID: 12700398
[TBL] [Abstract][Full Text] [Related]
19. Relationships between tissue levels of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), mRNAs, and toxicity in the developing male Wistar(Han) rat.
Bell DR; Clode S; Fan MQ; Fernandes A; Foster PM; Jiang T; Loizou G; MacNicoll A; Miller BG; Rose M; Tran L; White S
Toxicol Sci; 2007 Oct; 99(2):591-604. PubMed ID: 17656490
[TBL] [Abstract][Full Text] [Related]
20. 2,3,4,7,8-Pentachlorodibenzofuran is far less potent than 2,3,7,8-tetrachlorodibenzo-p-dioxin in disrupting the pituitary-gonad axis of the rat fetus.
Taura J; Takeda T; Fujii M; Hattori Y; Ishii Y; Kuroki H; Tsukimori K; Uchi H; Furue M; Yamada H
Toxicol Appl Pharmacol; 2014 Nov; 281(1):48-57. PubMed ID: 25220434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
